850074-42-9

Basic information

• Product Name: O2-ethyl O6-methyl benzothiophene-2,6-dicarboxylate
• Synonyms: 2-ethyl 6-methyl 1-benzothiophene-2,6-dicarboxylate; 2-Ethyl-6-methyl-1-benzothiophen-2,6-dicarboxylat
• CAS NO: 850074-42-9
• Molecular Formula: C₁₃H₁₂O₄S
• Molecular Weight: 264.3
• Mol File: 850074-42-9.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 388.1°C at 760 mmHg
• Flash Point: 188.5°C
• Density: 1.287g/cm³
• Vapor Pressure: 3.14E-06mmHg at 25°C
• Refractive Index: 1.604
• CAS DataBase Reference: O2-ethyl O6-methyl benzothiophene-2,6-dicarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: O2-ethyl O6-methyl benzothiophene-2,6-dicarboxylate(850074-42-9)
• EPA Substance Registry System: O2-ethyl O6-methyl benzothiophene-2,6-dicarboxylate(850074-42-9)

Safety Data

• Hazardous Substances Data: 850074-42-9(Hazardous Substances Data)

Upstream product

• 104447-80-5 (E)-1-(dimethylamino)-2-[4-(methoxycarbonyl)-2-nitrophenyl]ethene 
• 7356-11-8 4-methyl-3-nitro-benzoic acid methyl ester 
• 623-51-8 ethyl 2-sulfanylacetate 
• 153813-69-5 methyl 4-formyl-3-nitrobenzoate 
• 148625-35-8 methyl 3-formyl-4-nitrobenzoate 

Downstream Products

• 850074-43-0 benzo[b]thiophene-2,6-dicarboxylic acid 2-ethyl ester 
• 914452-64-5 (S)-tert-butoxycarbonylamino-{4-[4-({[2-(1-isobutoxy-ethoxycarbamoyl)-benzo[b]thiophen-6-ylmethyl]-amino}-methyl)-phenoxy]-phenyl}-acetic acid cyclopentyl ester 
• 914645-85-5 2-(S)-tert-butoxycarbonylamino-3-{4-[4-({[2-(1-isobutoxy-ethoxycarbamoyl)-benzo[b]thiophen-6-ylmethyl]-amino}-methyl)-phenoxy]-cyclohexyl}-propionic acid cyclopentyl ester 
• 102636-02-2 6-hydroxymethyl-benzo[b]thiophene-2-carboxylic acid 
• 914645-16-2 (S)-{[4-({[2-(1-isobutoxy-ethoxycarbamoyl)-benzo[b]thiophen-6-ylmethyl]-amino}-methyl)-cyclohexylmethyl]-amino}-phenyl-acetic acid tert-butyl ester 
• 914606-10-3 (S)-2-[4-({[2-(1-isobutoxy-ethoxycarbamoyl)-benzo[b]thiophen-6-ylmethyl]-amino}-methyl)-benzylamino]-3-phenyl-propionic acid cyclopentyl ester 
• 914606-40-9 (S)-[tert-butoxycarbonyl-(3-{[2-(1-isobutoxy-ethoxycarbamoyl)-benzo[b]-thiophen-6-ylmethyl]-amino}-benzyl)-amino]-phenyl-acetic acid cyclopentyl ester 
• 913739-27-2 C₂₅H₂₉N₃O₃S 
• 850074-68-9 6-[(4-methoxy-benzylamino)-methyl]-benzo[b]thiophene-2-carboxylic acid ethyl ester 

Relevant articles and documents

Benzocarbazoles five-membered unsaturated heterocyclic compound or its pharmaceutically acceptable salts and its preparation method, pharmaceutical composition and its application

Provided in the present invention are an unsaturated 5-membered benzo-heterocyclic compound with the structure as shown in general formula I or pharmaceutical salts thereof, and a preparation method, a pharmaceutical composition and the use thereof. Experiments have shown that the compound of the present invention has the effects of upregulating the expression activity of bone morphogenetic protein BMP-2 and anti-osteoporosis in vivo, and also has the effect of improving SAMP6 mice osteoporosis symptoms. Activity tests in vitro have shown that the compound of the present invention shows an obvious upregulation effect on bone morphogenetic protein BMP-2.

ORTHO AMINOAMIDES FOR THE TREATMENT OF CANCER

Compounds of formula are HDAC inhibitors. These compounds are useful for the treatment of diseases such as cancer in humans or animals.

HYDROXYALKYLARYLAMIDE DERIVATIVES

The present invention relates to a novel class of hydroxyalkylarylamide derivatives. The instant compounds can be used to treat cancer. The fluorinated arylamide derivatives can also inhibit histone deacetylase and are suitable for use in selectively indu